Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2010-10-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cca.2010.03.009PMID 20338160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later‐onset GLA mutation c.936+919G>A (IVS4+919G>A)

  2009cited by this paper
• Newborn screening for Krabbe disease: the New York State model.

  2009cited by this paper
• Implementation of newborn screening for Krabbe disease: population study and cutoff determination.

  2009cited by this paper
• Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry

  2008cited by this paper
• Fabry's disease.

  2008cited by this paper
• Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry.

  2008cited by this paper
• Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry.

  2006cited by this paper
• High incidence of later-onset fabry disease revealed by newborn screening.

  2006cited by this paper
• Newborn screening for lysosomal storage disorders.

  2006cited by this paper
• Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.

  2004cited by this paper
• Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

  2003cited by this paper
• Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

  2001cited by this paper
• Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

  2001cited by this paper
• Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

  1967cited by this paper

• c.640-814 T > C mutation in deep intronic region of alpha-galactosidase A gene is associated with Fabry disease via dominant-negative effect.

  2024cites this paper
• Multidisciplinary approach to screening and management of children with Fabry disease: practice at a Tertiary Children’s Hospital in China

  2021cites this paper
• Development of Strategies to Decrease False Positive Results in Newborn Screening

  2020cites this paper
• Emerging trends in paper spray mass spectrometry: Microsampling, storage, direct analysis, and applications.

  2019cites this paper
• The Fabry Family Determined as a Result of the Screening of the Transplanted Patients: A Single Center Screening

  2018cites this paper
• Synthesis of (3S,4S,5S)-trihydroxylpiperidine derivatives as enzyme stabilizers to improve therapeutic enzyme activity in Fabry patient cell lines.

  2018cites this paper
• Effect of temperature on lysosomal enzyme activity during preparation and storage of dried blood spots

  2018cites this paper
• Mass Spectrometry but not Fluorimetry Distinguishes Affected and Pseudodeficienies in Newborn Screening for Pompe Disease

  2017cites this paper
• Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease.

  2017cites this paper
• Age and gender-specific reference intervals for lysosomal enzymes in dried blood spot samples: A study in Indian population.

  2017cites this paper
• Rapid preparation of (3R,4S,5R) polyhydroxylated pyrrolidine-based libraries to discover a pharmacological chaperone for treatment of Fabry disease.

  2017cites this paper
• Validation of a Multiplex Tandem Mass Spectrometry Method for the Detection of Selected Lysosomal Storage Diseases in Dried Blood Spots

  2017cites this paper
• Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency.

  2016cites this paper
• Triplex tandem mass spectrometry assays for the screening of 3 lysosomal storage disorders in a Korean population.

  2016cites this paper
• The use of mass spectrometry to analyze dried blood spots.

  2016cites this paper
• Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.

  2015cites this paper
• Newborn screening for lysosomal storage diseases.

  2015cites this paper
• Nanofluidics-Based Mass Spectrometry. Applications for Biomarker Discovery in Lysosomal Storage Diseases

  2015cites this paper
• Improved Reagents for Newborn Screening of Mucopolysaccharidosis Types I, II, and VI by Tandem Mass Spectrometry

  2014cites this paper
• Fabry disease: a new approach for the screening of females in high-risk groups.

  2014cites this paper
• Newborn screening for hunter disease: a small-scale feasibility study.

  2014cites this paper
• Extended Neonatal Metabolic Screening By Tandem Mass Spectrometry: Models And Simulation Of Alternative Management Solutions

  2014cites this paper
• Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.

  2013cites this paper
• Diagnosing lysosomal storage diseases in a Brazilian non-newborn population by tandem mass spectrometry

  2013cites this paper
• Fabry patients' experiences with the timing of diagnosis relevant for the discussion on newborn screening.

  2013cites this paper
• Testing the feasibility of fully automated chip‐based nanoelectrospray ionization mass spectrometry as a novel tool for rapid diagnosis of Fabry disease

  2013cites this paper
• Diagnosing Lysosomal Storage Disorders: Fabry Disease

  2013cites this paper
• Sanfilippo disease (mucopolysaccharidosis type III): Early diagnosis and treatment

  2013cites this paper
• Analysis of Lyso-Globotriaosylsphingosine in Dried Blood Spots

  2013cites this paper
• Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.

  2012cites this paper
• A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2.

  2012cites this paper
• Newborn screening and renal disease: where we have been; where we are now; where we are going

  2012cites this paper
• First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene.

  2012cites this paper
• Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: application to a small-scale population study for five lysosomal storage disorders.

  2012cites this paper
• Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening.

  2012cites this paper
• Neonatal screening for lysosomal storage disorders.

  2012cites this paper
• Diagnosing Lysosomal Storage Disorders: Pompe Disease

  2012cites this paper
• Newborn screening for lysosomal storage disorders in hungary.

  2012cites this paper
• Set up and optimization of a tandem mass spectrometry procedure for enzymatic assays of lysosomal storage disorders and feasibility evaluations for a newborn screening program

  2012cites this paper
• Fabry disease: studies on diagnosis, screening and patients’ perspectives

  2012cites this paper
• Entwicklungen und Trends massenspektrometrischer Applikationen für das Neugeborenenscreening

  2012cites this paper
• Determinação da atividade de hidrolases lisossômicas em sangue colhido em papel filtro, uma alternativa para triagem em populações de alto risco

  2011cites this paper
• Analysis of trace metals in single droplet of urine by laser ablation inductively coupled plasma mass spectrometry

  2011cites this paper
• Influence of pre-analytical factors on α-galactosidase A, arylsulfatase B and α-glucosidase activities measured on dried blood spots on filter paper.

  2011cites this paper
• Analysis of glucocerebrosidase activity in dry blood spots using tandem mass spectrometry.

  2011cites this paper
• Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals

  2011cites this paper
• Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies.

  2011cites this paper
• Towards a selected reaction monitoring mass spectrometry fingerprint approach for the screening of oligosaccharidoses.

  2011cites this paper
• Simplified newborn screening protocol for lysosomal storage disorders.

  2011cites this paper
• Effect of sample collection, temperature and time of storage on β-galactosidase and total hexosaminidase activities in dried blood collected on filter paper

  2011cites this paper
• Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases.

  2011cites this paper
• Parents' Experiences of Expanded Newborn Screening Evaluations

  2011cites this paper
• The preparation and storage of dried-blood spot quality control materials for lysosomal storage disease screening tests.

  2011cites this paper
• The effect of preparation, storage and shipping of dried blood spots on the activity of five lysosomal enzymes.

  2011cites this paper
• Newborn bloodspot screening for lysosomal storage disorders.

  2011cites this paper